Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
06/2005
06/15/2005CN1626516A Novel intermediate for prepn. of pyrazolopyrimidinones
06/15/2005CN1626233A Drop pills for treating diseases of gynecology, and preparation method
06/15/2005CN1626232A Granules for treating diseases of gynecology, and preparation method
06/15/2005CN1626230A Capsule of Chinese traditional medicine for treating diseases caused by insufficiency of kidney-yang and deficiency of blood
06/15/2005CN1626228A Extractive from decoction of rehmannia including six elements, combination of medication, and medical use
06/15/2005CN1626219A 'Rukang' sticking piece prepared from cactus
06/15/2005CN1626207A Preparation including unique ingredient and fabricating method
06/15/2005CN1626197A Method for preparing external and internal remedies for treating diseases of AIDS, ulcer of oral cavity, burn and scald, and usage
06/15/2005CN1626196A Combination of Chinese traditional medicine for treating disease of cervical erosion, preparation and method of application
06/15/2005CN1626189A Medication for treating gynecopathies
06/15/2005CN1626179A Solid preparation of 'Fuxiekang' and preparation method
06/15/2005CN1626150A Medication for treating dysmenorhea
06/15/2005CN1626114A Spray agent of dried powder in use for diminishing inflammation of mucous membrane and preparation method
06/15/2005CN1626112A Method for preparing external and internal remedies for treating diseases of AIDS virus, burn and scald, and usage
06/15/2005CN1626106A Medication for preventing and treating diseases of pigs
06/15/2005CN1626095A Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
06/15/2005CN1626079A Fibrauretine injection preparation and preparing method
06/15/2005CN1626063A Preparation of vigor washing and nursing bag for male
06/15/2005CN1206241C Novel natural antibacterial peptide, its code sequence and application
06/15/2005CN1205964C Medicament for curing colpitismycotica and trichomonal vaginitis and its preparation method
06/15/2005CN1205963C Medicine for treating oophoritic cyst and its preparation process
06/15/2005CN1205958C Chinese material medica preparation for treating habitual abortion
06/15/2005CN1205957C Medicinal compsn. for treating woman diseases
06/15/2005CN1205948C Oral medicine for treating mastoplasia
06/15/2005CN1205937C Phosphatidic acid-comprising compositions
06/15/2005CN1205936C Novel contraceptive medicament and method for producing the same
06/14/2005US6906080 Antiinflammatory agents, analgesics, drug abuse, alcoholism
06/14/2005US6906075 Contacting a sample with substituted benzoimidazole analogues under conditions that permit binding of such analogue to melanin concentrating hormone (MCH) receptor to determine the presence and absence of MCH
06/14/2005US6906049 Contraceptive medicine based on a progestational agent and an oestrogen and preparation method
06/14/2005US6905688 Comprises therapeutic fusion proteins for diagnosis and treatment of cancers, neovascularization and autoimmune diseases
06/14/2005CA2346567C Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin
06/09/2005US20050124795 DNA encoding a human subunit 5-HT3-C of the 5-HT3 serotonin receptor
06/09/2005US20050124682 Such as N-{2-[5-(methylthio)-1H-indol-3-yl]ethyl}acetamide for treatment of disorders of the melatoninergic system; hormone replacement therapy
06/09/2005US20050124656 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps)
06/09/2005US20050124621 Novel inhibitors of kinases
06/09/2005US20050124605 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating circulatory, inflammatory, and proliferative disorders
06/09/2005US20050124592 Administering tibolone to female patients to treat estrogen-deficiency related, climacteric complaints exhibited while the female patients are being treated with a drug to prevent the biosynthesis of endogenous estrogen; aromatase inhibitors to prevent bone loss; reduced side efffcts for cancer patients
06/09/2005US20050124577 8-Azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
06/09/2005US20050124574 Purine derivatives
06/09/2005US20050124543 Heterologous polypeptide of the TNF family
06/09/2005US20050124004 Histamine receptor h3 polynucleotides
06/09/2005US20050123912 Nucleoprotein for use as tool in treatment, diagnosis and prevention of infection, cell proliferative, neurological, developmental, autoimmune and inflammatory disorders
06/09/2005US20050123629 Herbal medicine; menopause
06/09/2005US20050123551 Nucleic acids encoding polypeptides present in normal and neoplastic endometrial cells for use in diagnosis and treatment of endometrial cancer, identifying endometrial tissue; vectors, host cells; vaccines against endometrial cancer
06/09/2005US20050123512 Binding agents, vectors, host cells; gene therapy; nucleotide sequence with DNA insert encoding polypeptide; genetic engineering; medical diagnosis
06/09/2005US20050123508 human granulocyte colony stimulating factor polypeptides having amino acid replacements in the sequence, used for treating hematopoietic, neurological or reproductive disorders
06/09/2005CA2547051A1 Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions
06/09/2005CA2546703A1 Regulation of sperm function
06/09/2005CA2546498A1 Peptide increasing fusiogenic capacity of a gamete
06/08/2005EP1538160A1 Substituted Isoquinolin-3-carboxyamides, their preparation and medical use
06/08/2005EP1537243A1 Method of diagnosing ovarian endometriosis
06/08/2005EP1537129A1 Akt inhibitors, pharmaceutical compositions, and uses thereof
06/08/2005EP1537086A2 Novel phenanthridines
06/08/2005EP1537085A1 Oxytocin inhibitors
06/08/2005EP1537084A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of
06/08/2005EP1536850A1 Medical device having hydration inhibitor
06/08/2005EP1536797A1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related comounds as neurokinin-1 (nk-1) antagonsists for the treatment of emesis, depression, anxiety and cough
06/08/2005EP1536777A1 Use of nf-kappa b inhibitors for the treatment of mastitis
06/08/2005EP1458706A4 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor
06/08/2005EP1441769B1 Pharmaceutical formulations containing low concentrations of peroxide for treating or preventing vaginal infections
06/08/2005EP1414937B1 Hops extracts, method for the production and use
06/08/2005EP1259514B1 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
06/08/2005EP1231925B1 Method and composition for the treatment of adenoviral ocular infections
06/08/2005EP1220831B1 Biaryl ether derivatives useful as monoamine reuptake inhibitors
06/08/2005EP1001797B1 Soya extract, process for its preparation and pharmaceutical composition
06/08/2005CN1625558A Aza-arylpiperazines
06/08/2005CN1625556A Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions
06/08/2005CN1625553A Treatment of male sexual dysfunction
06/08/2005CN1623604A Process for controlling birth female of mammal based on SRY gene
06/08/2005CN1623599A Xiaoyao soft capsule and its preparation technology
06/08/2005CN1623594A Powder for treating oophoritic cyst
06/08/2005CN1623577A Preparation method of medicine for raising teem quantity of live pig
06/08/2005CN1623573A Biological preparation garlic bactericidal oil pill for gynecopathy use and its manufacturing method
06/08/2005CN1623550A Hydroxy progesterone caproate oral preparation and its use
06/08/2005CN1205219C Unsaturated 14,15-cyclopropane-cendrostanes, a method for their production and pharmaceutical compositions containing these compounds
06/08/2005CN1204917C Complex rhizoma paridis tincture and preparing method thereof
06/08/2005CN1204892C Formulations for reducing or eliminating toxicity of environmental hormones containing ursodeoxycholic acid
06/07/2005US6903132 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use
06/07/2005US6903127 Sexual disorders
06/07/2005US6903120 Modulators of dopamine neurotransmission
06/07/2005US6903102 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
06/07/2005US6903099 Heterocyclic amides used as preferential inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase, for prophylaxis of cardiovascular disorders and erectile dysfunction
06/07/2005US6903089 Lactam-substituted pyrazolopyridine derivatives
06/07/2005US6903087 Pyrido cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
06/07/2005CA2281090C Sulfonamide compounds and salts for treatment of endothelin-mediated disorders
06/02/2005WO2005049627A1 Isoflavonoid prodrugs, compositions thereof and therapeutic methods involving same
06/02/2005WO2004112832A3 Immunogenic compositions comprising multiple gonococcal antigens
06/02/2005WO2003075847A3 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS
06/02/2005US20050119489 Antidiabetic, anorexigenic, hypotensive, and anticholesterol agents that are synergistically combined with other active agents; obesity, premenstrual tension, hyperlipidemia, myocardial infarction and skin disorders
06/02/2005US20050119465 Glycosylated follicle stimulating hormone for use as therapeutic tool in treatment of reproductive disorders
06/02/2005US20050119458 Transport protein for use in identifying modulator for prevention and treatment of cell proliferative, skin and psychological disorders; anticonvulsants; insecticides; pesticides; anthelmintics
06/02/2005US20050119333 Compositions comprising ether compounds and pharmaceutical uses therefor
06/02/2005US20050119321 2-substituted-1,3-thiazole compounds
06/02/2005US20050119250 Amino-derivatives as novel inhibitors of histone deacetylase
06/02/2005US20050118244 penetration promoter; hormone replacement therapy; contraception
06/02/2005US20050118242 Using testosterone; topical applying to skins
06/02/2005US20050118232 N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids
06/02/2005CA2546643A1 Isoflavonoid prodrugs, compositions thereof and therapeutic methods involving same
06/01/2005EP1535915A1 Furan or thiophene derivative and medicinal use thereof
06/01/2005EP1535620A1 The use of n-acetyl-d-glucosamine for preparing medicines for urogenital tract infection's treatment and prevention